Authors


Elizabeth W. Covington, PharmD, BCIDP

Latest:

Precision Bayesian Modeling Tailors Vancomycin Dosing in Patients With Obesity

The future of vancomycin dosing lies in optimizing dosing regimens to individual patient needs.


Lexie Frint

Latest:

Clinical Insight: The Use of GLP-1 Agonist Medications for Weight Loss

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.


Andrew Britton, PharmD, MBA

Latest:

Examining an Important Orphan Disease: Neurotrophic Keratitis/Keratopathy and Its Treatment

NK is a degenerative corneal disease resulting from diminished corneal innervation.


Alexander Swick, PharmD, MBA

Latest:

A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance Reports

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.



Rhea Bowman, PharmD

Latest:

Empower Prospective Pharmacists through Children’s Books

This short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.


Beena Wood

Latest:

Pharma Can Help Transform Patient Centricity in 2024

True patient centricity treats the whole patient and places an emphasis on broader patient engagement and satisfaction.


Aaron Johnson, PharmD

Latest:

Addressing Racial Disparities in Opioid Prescriptions: The Role of Pharmacists in Achieving Equity

Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.


Khanh Huynh, PharmD, BCACP, APh

Latest:

Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical Practice

Systemic treatment options have historically been limited to traditional chemotherapy agents.


Kara Sammons, MSPharmReg, CPhT

Latest:

Tackling the Growing Impact of Orphan Drug Designation and Limited Distribution Networks in Oncology

Pharmacy teams are learning to adapt to the challenges of limited distribution networks and orphan drug designation in oncology, with integrated pharmacy support playing a crucial role in enhancing patient access and adherence.


Ryan Kurschner

Latest:

Clinical Overview: Cyletzo, a Biosimilar Version of Adalimumab

Indications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.


Joseph Mashni, Jr., MD

Latest:

Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary Oncologists

For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.


Moura Maseha, PharmD

Latest:

Behind the Counter Codeine Preparations Require Diligent Care

It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.


Rebecca Medva, MHMS, BS, CPhT

Latest:

Developing and Implementing Immunization Standing Orders and Protocols

Vaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.


Matthew Chui, PharmD, BCOP

Latest:

The Phase 3 AMPLIFY Trial Assesses a New Treatment Paradigm in Patients With Treatment-Naive CLL

Investigators assessed fixed-duration venetoclax plus acalabrutinib with or without obinutuzumab vs chemoimmunotherapy.


Anne Dang-Vo

Latest:

The Role of Tirofiban for Acute Coronary Syndrome Remains Unclear

The RESCUE BT2 trial sheds further light on the agent’s potential.


Liping Ma, PhD

Latest:

Unlocking PROTACs’ Potential: Overcoming Development Challenges

Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.


Emily Wilkerson, PharmD

Latest:

Pharmacy Colorectal Cancer Screening Protocol Shows Potential of Pharmacists in Preventative Health

The opportunity to provide non-invasive colorectal cancer screening and education to patients is undoubtedly a role that pharmacists can fill.





Amy L. Carr, PharmD, BCIDP

Latest:

Fecal Microbiota, Live-jslm for the Prevention of Recurrent C difficile Infection

Pharmacists play a key role in the use of live biotherapeutic products, including fecal microbiota, live-jslm for prevention of recurrent Clostridioides difficile (C difficile) infection.


Nirav Pandya, PharmD, RPh

Latest:

Common Medication Errors in LTC Communities: What Pharmacists Can Do To Help Prevent Them

The most common medication errors seen in LTC facilities include dispensing errors, delay in delivery, and expired inventory.


Micah Cost, PharmD, MS, Chief Executive Officer, Pharmacy Quality Alliance

Latest:

Pharmacy Measures and Policy Considerations for Pharmacy Practice

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.


Christina Billias, PharmD

Latest:

Antineoplastic Extravasation Prevention, Management

Extravasation is defined as the inadvertent leakage of a vesicant from the vein into the surrounding tissue.


Sheikh Zakaria, PharmD

Latest:

Patient Case Study: Use of Dietary Supplements in Patients With Breast Cancer

Even when safe, oral supplement use may not be appropriate to use during cancer treatment or recovery.


Rebecca M. Khaimova, PharmD, BCACP, CDCES

Latest:

A Pharmacist’s Guide to Continuous Glucose Monitoring

This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.


Peter T.Gordinier Jr, PharmD Candidate

Latest:

Distinguishing Between Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome

Although small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) share many of the same symptoms, SIBO affects the small intestine and IBS affects the large intestine.


Glenn S Tillotson PhD, FIDSA

Latest:

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.


Julia Settler, PharmD, MBA

Latest:

Clinical Overview: Elfabrio for Fabry Disease in Adults

Fabry disease is a rare X-linked, lysosomal storage disorder that can cause renal failure or stroke.